Summary:
CNS Network is conducting a randomized, double blind, multicenter, parallel group, outpatient study evaluating the efficacy and safety of dasotraline in adults with ADHD.
Ages Eligible for Study: 18 Years to 55 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Inclusion Criteria:
- Subject is male or female, 18 to 55 years old, inclusive, at the time of informed consent.
- Primary diagnosis of ADHD (inattentive, hyperactive, or combined subtype) established by a comprehensive psychiatric evaluation that reviews psychiatric criteria.
Qualified Participants May Receive:
Study-related medical care and study medication at no cost and may be compensated for time and travel.